BC
MRK icon

Bayforest Capital’s Merck MRK Stock Holding History

Bayforest Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$74.8K Sell
515
-804
-61% -$111K 0.11% 366
2026
Q2 		$169K Buy
+1,319
New +$154K 0.16% 225
2025
Q3 		– Sell
-2
Closed -$158 – 852
2025
Q2 		$158 Sell
2
-3,074
-100% -$244K ﹤0.01% 711
2025
Q1 		$276K Buy
3,076
+2,647
+617% +$247K 0.12% 319
2024
Q4 		$42.7K Buy
+429
New +$44.2K 0.05% 493

Other funds holding MRK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Bayforest Capital's MRK Position: Q3 2026 in Review

Bayforest Capital reduced its Merck (MRK) stake by 61% in Q3 2026, selling an estimated $111K and leaving 515 shares worth $74.8K. The position accounts for 0.11% of the portfolio, ranked #366.

Bayforest Capital first reported a position in MRK in Q4 2024 and has held it in 5 quarters since. The position peaked at $276K in Q1 2025. 2,669 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Bayforest Capital held 515 shares of Merck worth $74.8K as of Q3 2026.
  • Bayforest Capital sold 804 Merck shares in Q3 2026, an estimated $111K.
  • Merck made up 0.11% of Bayforest Capital's portfolio in Q3 2026, its #366 holding.
  • Bayforest Capital first reported a position in Merck in Q4 2024 and has held it in 5 quarters since.
  • Bayforest Capital's Merck position peaked at $276K in Q1 2025.
  • 2,669 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.